新泰醫藥 MDGL 深 滬
等待開盤 03-26 09:30:00 美东时间
461.93
+16.890
+3.80%
華盛通- 最 高471.72
- 今 開448.79
- 成交量 30.35万股
- 最 低 448.49
- 昨 收 445.04
- 總市值 105.97亿
- 52周最高 615.00
- 市盈率 靜 --
- 換手率 1.32%
- 52周最低 265.00
- 委 比 -83.97%
- 總股本 2294.00万
- 歷史最高 615.00
- 量 比 0.93
- 振 幅 5.22%
- 歷史最低 5.25
- 每 手 1
- 風險率 97.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Madrigal Pharmaceuticals granted equity awards to seven new non-executive employees under its 2025 Inducement Plan, totaling 1,739 time-based restricted stock units. The awards, approved by the independent Compensation Committee, vest annually over four years contingent on continued employment. Madrigal focuses on developing therapies for metabolic dysfunction-associated steatohepatitis (MASH), with its approved drug Rezdiffra targeting the disea...
03-19 20:05
Madrigal Pharmaceuticals EVP and CFO Mardi Dier Disposes of Common Shares
Madrigal Pharmaceuticals EVP and CFO Mardi Dier Disposes of Common Shares Mardi Dier, EVP and CFO of Madrigal Pharmaceuticals Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologi
03-07 08:19
Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Madrigal Pharmaceuticals (NASDAQ:MDGL) has been analyzed by 5 analysts in the l...
02-21 04:01
BUZZ-U.S. STOCKS ON THE MOVE- Etsy, Helmerich and Payne, Integer Holdings
BUZZ-U.S. STOCKS ON THE MOVE- Etsy, Helmerich and Payne, Integer Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Thursday, following a thr
02-19 23:41
Madrigal Pharmaceuticals shares are trading lower after the company reported mixed Q4 financial results.
Madrigal Pharmaceuticals shares are trading lower after the company reported mi...
02-19 21:49
Madrigal down after wider-than-expected Q4 loss
Madrigal Pharmaceuticals (MDGL) lost ~8% in the premarket on Thursday after the maker of the liver disease therapy, Rezdiffra, posted a mixed financial report for Q4 2025, indicating a worse-than-expe...
02-19 21:09
财报速睇 | 新泰医药 2025财年Q4营收3.21亿美元，同比增长211.7%；归母净利润亏损0.58亿美元，同比亏损缩窄1.7%
华盛资讯2月19日讯，新泰医药公布2025财年Q4业绩，公司Q4营收3.21亿美元，同比增长211.7%，归母净利润亏损0.58亿美元，同比亏损缩窄1.7%。
02-19 20:17
Madrigal Pharmaceuticals Q4 revenue rises sharply on Rezdiffra sales
Madrigal Pharmaceuticals Q4 revenue rises sharply on Rezdiffra sales Overview Biopharmaceutical firm reported Q4 revenue of $321.1 mln, up significantly from last year Company reported net loss for Q4 despite revenue growth Company expanded MASH pipeline with new programs and partnerships Outlook Ma
02-19 20:10
Madrigal posts FY 2025 net revenues of USD 958.4 million
Madrigal posts FY 2025 net revenues of USD 958.4 million Madrigal Pharmaceuticals reported Q4 2025 product revenue, net of USD 321.08 million and FY 2025 product revenue, net of USD 958.4 million, driven by Rezdiffra (resmetirom). The company posted a Q4 2025 net loss of USD 58.58 million and an FY
02-19 20:04
